Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
JAAPA ; 35(7): 32-34, 2022 Jul 01.
Article in English | MEDLINE | ID: mdl-35762953

ABSTRACT

ABSTRACT: This article describes an 18-year-old immunocompetent patient who developed Mycobacterium kansasii, manifested with shortness of breath and a cavitary lung lesion seen on radiograph. Initial sputum smears were negative; however, after 2 weeks, the cultures grew M. kansasii and the patient was started on an antimycobacterial regimen.


Subject(s)
Mycobacterium Infections, Nontuberculous , Mycobacterium kansasii , Adolescent , Anti-Bacterial Agents/therapeutic use , Humans , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Radiography
2.
JAAPA ; 32(7): 1-6, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31241616

ABSTRACT

Neuromyelitis optica, also known as Devic disease, is an autoimmune disorder that affects the spinal cord and optic nerve. This atypical demyelinating syndrome can be difficult to diagnose and responds poorly to treatments that are used for multiple sclerosis, a similar demyelinating disease. This article discusses the epidemiology, pathophysiology, clinical presentation, latest diagnostic criteria, and treatment options for neuromyelitis optica and neuromyelitis spectrum disorders.


Subject(s)
Brain/diagnostic imaging , Neuromyelitis Optica/diagnosis , Spinal Cord/diagnostic imaging , Adult , Aquaporin 4/immunology , Autoantibodies/immunology , Female , Glucocorticoids/therapeutic use , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Magnetic Resonance Imaging , Neuromyelitis Optica/epidemiology , Neuromyelitis Optica/immunology , Neuromyelitis Optica/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...